Apr 30, 2026
Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, highlights the critical role of advanced precision diagnostics and how these tools are driving true precision medicine, where therapies are targeted to specific genetic mutations. There have been significant innovations, such as less invasive liquid...
Apr 30, 2026
Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, highlights the critical role of advanced precision diagnostics and how these tools are driving true precision medicine, where therapies are targeted to specific genetic mutations. There have been significant innovations, such as less invasive liquid...
Apr 16, 2026
Robert Schickel, Chief Executive Officer at NUAgo Therapeutics, is developing a cancer therapy using short RNAs to target and disrupt interconnected survival genes in cancer cells. The therapy has been shown to be non-toxic to healthy cells, which have high levels of microRNAs, whereas cancer cells downregulate...
Apr 16, 2026
Dr. Babak Saboury, Chief Scientific and Innovation Officer and Physician Founder of United Theranostics, discusses the emergence of nuclear oncology as the fourth pillar of cancer care. United Theranostics is combining advanced molecular imaging and radiopharmaceutical therapies to identify a cancer cell's unique...
Apr 16, 2026
Dr. Babak Saboury, Chief Scientific and Innovation Officer and Physician Founder of United Theranostics, discusses the emergence of nuclear oncology as the fourth pillar of cancer care. United Theranostics is combining advanced molecular imaging and radiopharmaceutical therapies to identify a cancer cell's unique...